Eva Liang, MD
Ophthalmology · Las Vegas, NVNPI 1619957081
Payments from drug & device makers
Across 1,106 payments — averaging $2021.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$611K
- Alcon Research LLC$456K
- Rxsight Inc$305K
- Beaver-visitec International, Inc.$227K
- Bausch & Lomb Americas Inc.$180K
- Johnson & Johnson Surgical Vision, Inc.$150K
- plus $307K from 24 others
Across 30 payments — averaging $3920.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beaver-visitec International, Inc.$94K
- Bausch & Lomb Americas Inc.$12K
- Rxsight Inc$8K
- Glaukos Corporation$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 270 | $611,409 |
| Alcon Research LLC | 137 | $456,376 |
| Rxsight Inc | 180 | $304,991 |
| Beaver-visitec International, Inc. | 3 | $226,605 |
| Bausch & Lomb Americas Inc. | 53 | $179,580 |
| Johnson & Johnson Surgical Vision, Inc. | 83 | $149,557 |
| Bausch Health US, LLC | 11 | $102,291 |
| AbbVie(2 entities) | 80 | $68,534 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 97 | $43,025 |
| Ivantis, Inc | 29 | $32,178 |
| Sun Pharmaceutical Industries Inc. | 33 | $23,664 |
| Oyster Point Pharma, Inc. | 16 | $13,314 |
| Alcon | 57 | $13,287 |
| Kala Pharmaceuticals, Inc. | 13 | $6,073 |
| Eyevance Pharmaceuticals LLC | 8 | $1,528 |
| Lensar, Inc. | 1 | $1,500 |
| Tarsus Pharmaceuticals, Inc. | 8 | $345 |
| Amgen(2 entities) | 3 | $264 |
| Rayner Intraocular Lenses Limited | 2 | $243 |
| Sight Sciences, Inc. | 4 | $242 |
| Carl Zeiss Meditec, Inc. | 4 | $221 |
| Kestra Medical Technology Services, Inc. | 1 | $158 |
| Dompe US, Inc. | 4 | $96 |
| Novartis | 2 | $42 |
| Carl Zeiss Meditec USA, Inc. | 2 | $39 |
| Harrow Eye, LLC | 1 | $31 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Shire North American Group Inc | 1 | $16 |
| Biotissue Holdings Inc. | 1 | $14 |
| Medline Industries LP | 1 | $13 |
How this compares
$2,235,654 in reported general payments places this provider in the 95th percentile of 121 ophthalmology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Las Vegas
- Matthew SwanicLas Vegas$433K
- Nelson LopezLas Vegas$193K
- Kent WellishLas Vegas$185K
- Allen ThachLas Vegas$173K
- Steven LeibowitzLas Vegas$157K
- Michael PernulaLas Vegas$149K
- Matthew PezdaLas Vegas$136K
- Mark DoubravaLas Vegas$66K
- Emil SteinLas Vegas$57K
- Jack AbramsLas Vegas$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.